Related Experiment Video
Updated: May 7, 2026

Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria
Reidun Øvstebø1, Marit Hellum2, Hans Christian D Aass3
1Blood Cell Research Group, Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway reidun.ovstebo@ous-hf.no.
Abstract:
Neisseria meningitidis causes fulminant meningococcal sepsis with a massive activation of the coagulation and complement cascades. Bacterial cell envelope molecules from N. meningitidis, particularly lipopolysaccharide (LPS), induce tissue factor (TF) expression. In meningococcal sepsis, TF can be detected on circulating monocytes and microparticles (MPs) within the bloodstream. During infection, Nm activates C5 and C5a, which also is able to induce TF. We evaluated the effect of eculizumab, a C5-blocking monoclonal antibodies (mAb), on cell- and MP-associated TF. Using a lepirudin-anticoagulated whole blood model, we activated the coagulation and complement cascades by N. meningitidis, and investigated the interaction between the cascade systems with special focus on cell-associated TF-expression (mRNA and protein) and MP-associated TF-dependent thrombin and fibrin generation in platelet-free plasma. We also examined the ability of TF-positive MPs to support clot formation in whole blood. In addition, the effect of corn trypsin inhibitor and time-dependent changes on MP-associated functional TF activity was examined. Inhibition of C5 reduced cell-associated TF expression at both gene and protein level, and reduced MP-associated TF-dependent thrombin and fibrin generation in platelet-poor plasma, MP-induced TF-dependent clot formation in whole blood, implying that the complement and coagulation cascades are interplayers in N. meningitidis-mediated activation of these cascades.
Insights
Eculizumab, a C5 inhibitor, reduced tissue factor (TF) expression and thrombin generation in a model of meningococcal sepsis. This suggests complement C5 plays a key role in sepsis-induced coagulation activation.
Area of Science:
- Microbiology
- Immunology
- Hematology
Background:
- Neisseria meningitidis causes severe sepsis by activating coagulation and complement systems.
- Bacterial molecules like lipopolysaccharide (LPS) trigger tissue factor (TF) expression on monocytes and microparticles (MPs).
- Complement component C5 activation by N. meningitidis also induces TF expression.
Purpose of the Study:
- To investigate the impact of eculizumab, a C5-blocking antibody, on cell- and MP-associated TF.
- To explore the interplay between complement and coagulation cascades in meningococcal sepsis.
Main Methods:
- A whole blood model was used, anticoagulated with lepirudin.
- Coagulation and complement cascades were activated by N. meningitidis.
- TF expression (mRNA, protein), TF-dependent thrombin and fibrin generation, and TF-positive MP clot formation were analyzed.
Main Results:
- Inhibition of C5 significantly reduced cell-associated TF expression at both gene and protein levels.
- C5 inhibition decreased MP-associated TF-dependent thrombin and fibrin generation.
- Eculizumab also reduced MP-induced TF-dependent clot formation in whole blood.
Conclusions:
- Complement component C5 is a critical mediator in N. meningitidis-induced TF expression and subsequent coagulation activation.
- The complement and coagulation cascades are interconnected in meningococcal sepsis.
- Targeting C5 may offer a therapeutic strategy for sepsis-induced coagulopathy.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Complement System

